PUBLISHER: IMARC | PRODUCT CODE: 1467574
PUBLISHER: IMARC | PRODUCT CODE: 1467574
United States Platelet Rich Plasma Market Report by Product Type (Pure Platelet-Rich Plasma, Leukocyte- and Platelet-Rich Plasma, Leukocyte- and Platelet-Rich Fibrin, Pure Platelet-Rich Fibrin ), Origin, Application, End User, and Region 2024-2032
The United States platelet rich plasma market size reached US$ 249.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 546.2 Million by 2032, exhibiting a growth rate (CAGR) of 8.8% during 2024-2032.
Platelet-rich plasma (PRP) refers to a concentrated plasma protein that contains minor quantities of red blood cells. The platelets are suspended in a small amount of plasma after centrifugation and stimulate healing when injected into the body. PRP is widely administered by non-invasive therapies for long-lasting rejuvenation of ligaments and muscle fibers. Some of the common variants of PRP include pure platelet-rich plasma (P-PRP), leukocyte- and platelet-rich plasma (LPRP), leukocyte- and platelet-rich Fibrin (L-PRF), and pure platelet-rich fibrin (P-PRF).
The rising prevalence of chronic tendon injuries in vital organs is currently bolstering the demand for PRP-based therapies in the US. Furthermore, increasing adoption of effective therapies for treating muscle and acute ligament tearing, arthritis, fractures, orthopedic impairments, etc., is also propelling the market growth. In line with this, the growing awareness towards numerous benefits of PRP treatment in preventing inflammation, encouraging new cartilage formulation, and inducing natural lubrication fluid production, is further augmenting the product demand in the country. Moreover, the rising deployment of advanced healthcare facilities for sports clubs and teams is also catalyzing the adoption of PRP-based therapies for treating common injuries in athletes, such as lumbar spine disc pain, rotator cuff injuries, shoulder pain and instability, tennis/golfer's elbow, etc. Apart from this, the expanding cosmetic surgery sector in the United States is further driving the utilization of PRP-based procedures for improving facial shape and volume. In the coming years, the increasing healthcare expenditures along with the rising demand for non-invasive medical procedures will continue to spur the demand for PRP-based therapies in the United States.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the United States platelet rich plasma market report, along with forecasts at the country level from 2024-2032. Our report has categorized the market based on product type, origin, application, and end user.
Breakup by Product Type:
Pure Platelet-Rich Plasma (P-PRP)
Leukocyte- and Platelet-Rich Plasma (LPRP)
Leukocyte- and Platelet-Rich Fibrin (L-PRF)
Pure Platelet-Rich Fibrin (P-PRF)
Breakup by Origin:
Autologous PRP
Homologous PRP
Allogeneic PRP
Breakup by Application:
Orthopedics
Cosmetic Surgery and Dermatology
Neurosurgery
General Surgery
Cardiothoracic Surgery
Urology
Ophthalmology
Others
Breakup by End User:
Hospitals and Clinics
Research Institutes
Others
Breakup by Region:
Northeast
Midwest
South
West
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Arteriocyte Medical Systems Inc. (Isto Technologies II LLC), Arthrex Inc., Depuy Synthes, Inc. (Johnson & Johnson), Dr Prp USA LLC, EmCyte Corporation, Exactech Inc., Glofinn America LLC (Glofinn Co. Ltd.), Regen Lab USA LLC, Stryker Corporation, Terumo BCT Inc. (Terumo Corporation), ThermoGenesis Holdings Inc. and Zimmer Biomet Holdings Inc.
Key Questions Answered in This Report
- 1. What was the size of the United States platelet rich plasma market in 2023?
- 2. What is the expected growth rate of the United States platelet rich plasma market during 2024-2032?
- 3. What are the key factors driving the United States platelet rich plasma market?
- 4. What has been the impact of COVID-19 on the United States platelet rich plasma market?
- 5. What is the breakup of the United States platelet rich plasma market based on the product type?
- 6. What is the breakup of the United States platelet rich plasma market based on the origin?
- 7. What is the breakup of the United States platelet rich plasma market based on the application?
- 8. What is the breakup of the United States platelet rich plasma market based on the end user?
- 9. What are the key regions in the United States platelet rich plasma market?
- 10. Who are the key players/companies in the United States platelet rich plasma market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 United States Platelet Rich Plasma Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Pure Platelet-Rich Plasma (P-PRP)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Leukocyte- and Platelet-Rich Plasma (LPRP)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Leukocyte- and Platelet-Rich Fibrin (L-PRF)
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Pure Platelet-Rich Fibrin (P-PRF)
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Origin
- 7.1 Autologous PRP
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Homologous PRP
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Allogeneic PRP
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Application
- 8.1 Orthopedics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Cosmetic Surgery and Dermatology
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Neurosurgery
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 General Surgery
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Cardiothoracic Surgery
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Urology
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Ophthalmology
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
- 8.8 Others
- 8.8.1 Market Trends
- 8.8.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Research Institutes
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 Northeast
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Midwest
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 South
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 West
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 SWOT Analysis
- 15.3.2 Arthrex Inc.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Depuy Synthes Inc. (Johnson & Johnson)
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.4 Dr Prp USA LLC
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 EmCyte Corporation
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Exactech Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Glofinn America LLC (Glofinn Co. Ltd.)
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Regen Lab USA LLC
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Stryker Corporation
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Terumo BCT Inc. (Terumo Corporation)
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 ThermoGenesis Holdings Inc.
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.12 Zimmer Biomet Holdings Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
- 15.3.12.3 Financials
- 15.3.12.4 SWOT Analysis
- 15.3.1 Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
List of Figures
- Figure 1: United States: Platelet Rich Plasma Market: Major Drivers and Challenges
- Figure 2: United States: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018-2023
- Figure 3: United States: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: United States: Platelet Rich Plasma Market: Breakup by Product Type (in %), 2023
- Figure 5: United States: Platelet Rich Plasma Market: Breakup by Origin (in %), 2023
- Figure 6: United States: Platelet Rich Plasma Market: Breakup by Application (in %), 2023
- Figure 7: United States: Platelet Rich Plasma Market: Breakup by End User (in %), 2023
- Figure 8: United States: Platelet Rich Plasma Market: Breakup by Region (in %), 2023
- Figure 9: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma (P-PRP)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma (P-PRP)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma (LPRP)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma (LPRP)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin (L-PRF) ) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin (L-PRF) ) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin (P-PRF)) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin (P-PRF)) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: United States: Platelet Rich Plasma (Autologous PRP) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: United States: Platelet Rich Plasma (Autologous PRP) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: United States: Platelet Rich Plasma (Homologous PRP) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: United States: Platelet Rich Plasma (Homologous PRP) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: United States: Platelet Rich Plasma (Allogeneic PRP) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: United States: Platelet Rich Plasma (Allogeneic PRP) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: United States: Platelet Rich Plasma (Orthopedics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: United States: Platelet Rich Plasma (Orthopedics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: United States: Platelet Rich Plasma (Neurosurgery) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: United States: Platelet Rich Plasma (Neurosurgery) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: United States: Platelet Rich Plasma (General Surgery) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: United States: Platelet Rich Plasma (General Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: United States: Platelet Rich Plasma (Urology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: United States: Platelet Rich Plasma (Urology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: United States: Platelet Rich Plasma (Ophthalmology) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: United States: Platelet Rich Plasma (Ophthalmology) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: United States: Platelet Rich Plasma (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: United States: Platelet Rich Plasma (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: United States: Platelet Rich Plasma (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: United States: Platelet Rich Plasma (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: United States: Platelet Rich Plasma (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: United States: Platelet Rich Plasma (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: United States: Platelet Rich Plasma (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: United States: Platelet Rich Plasma (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Northeast: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Northeast: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Midwest: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Midwest: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: South: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: South: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: West: Platelet Rich Plasma Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: West: Platelet Rich Plasma Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: United States: Platelet Rich Plasma Industry: SWOT Analysis
- Figure 54: United States: Platelet Rich Plasma Industry: Value Chain Analysis
- Figure 55: United States: Platelet Rich Plasma Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: United States: Platelet Rich Plasma Market: Key Industry Highlights, 2023 and 2032
- Table 2: United States: Platelet Rich Plasma Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
- Table 3: United States: Platelet Rich Plasma Market Forecast: Breakup by Origin (in Million US$), 2024-2032
- Table 4: United States: Platelet Rich Plasma Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: United States: Platelet Rich Plasma Market Forecast: Breakup by End User (in Million US$), 2024-2032
- Table 6: United States: Platelet Rich Plasma Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: United States: Platelet Rich Plasma Market: Competitive Structure
- Table 8: United States: Platelet Rich Plasma Market: Key Players
